期刊文献+

影响血脑屏障的因素 被引量:3

原文传递
导出
摘要 脑水肿是神经系统疾病的基本病理过程,与神经系统疾病治疗关系密切,血脑屏障(BBB)为脑组织与外界进行营养物质交流的系统,它保证了中枢神经组织内环境的稳定。血脑屏障的损伤在脑水肿的发生发展中起重要作用。研究表明,多重因素参与了BBB结构功能的改变和破坏,而BBB结构功能的变化是脑水肿病理变化的重要环节。探讨影响血脑屏障通透性的因素,可为临床治疗方案的优化提供理论依据。
出处 《国外医学(神经病学.神经外科学分册)》 2003年第5期434-437,共4页 Foreign Medical Sciences(Section On Neurology & Neurosurgery)
  • 相关文献

参考文献23

  • 1Zheng W. Neurotoxicology of the brain barrier system: new implications. J Toxicol Clin Toxicol 2001,39(7) :711 - 719.
  • 2Cucullo L, McAllister MS, Kight K, et al. A new dynamic in vitro model for the multidimensional study of astrocyte-endothelial cell interactions at the blood-brain barrier. Brain Res, 2002, 951(2):243.
  • 3Marchi N, Fazio V, Cueullo L, et al.Serum transthyretin monomer as a possible marker of blood - to - CSF barrier disruption. J Neurosci ,2003 , 23(5) : 1949 - 1955.
  • 4Gloor SM, Wachtel M, Bolliger MF, et al. Molecular and cellular permeability control at the blood - brain barrier. Brain Res Rev,2001,36(2-3): 258-264.
  • 5Abbott NJ. Astmcyte - endothelial interactions and blood - brain barrier permeability. J Anat , 2002 ,200(6) :629 - 638.
  • 6Descamps L, Coisne C, Dehouck B, et al. Protective effect of glial cell against lipopolysaccharide - mediated blood - brain barrier injury. Glia,2003 , 42(1):46-58.
  • 7Iida H, Iida M, Takenaka M, et al. The effects of alpha - human atrial natriuretic peptide and milrinone on pial vessels during Mood - brain barrier disruption in rabbits. Anesth Analg, 2001 , 93(1):177- 182.
  • 8Kaya M, Cimen V, Kalayci R, et al. Cetalase and alpha - tocopherol attenuate blood - brain barrier breakdown in pentylenetetrazole-induced epileptic seizures in acute hyperglycaemic rats. Pharmacol Res,2002, 45(2) :129 - 133.
  • 9Oztas B, Kilic S, Dural E, et al. Influence of antioxidants on the blood - brain barrier permeability during epileptic seizures. J Neurosci Res ,2001 , 66(4) :674 - 678.
  • 10Schilling L, Wahl M. Mediators of cerebral edema. Adv Exp Med Biol ,1999,474:123 - 141.

同被引文献23

  • 1赵喜林,顾振纶,秦正红.长期低剂量皮下注射鱼藤酮制作大鼠帕金森病模型[J].中国药理学通报,2005,21(10):1274-1277. 被引量:27
  • 2张琳,刘树民.刺五加防治帕金森病研究进展[J].中国中医药信息杂志,2007,14(3):95-96. 被引量:7
  • 3诸葛启钏.大鼠脑立体定位图谱(第3版).北京:人民卫生出版社,2005∶82.
  • 4国家药典委员会.中国药典(2010年版).北京:中国医药科技出版社,2010:192.
  • 5Baqqer MA, Bechqaard E. The potential of nasal application for de- livery to the central brain-a microdialysis study of fluorescein in rats. Eur J Pharm Sci, 2004, 21(2):235-242.
  • 6Hirsch EC, Hunot S, Damier P, et ol. Glial cells and inflammation in Parkinson's disease: a role in neurodegeneration. Ann Neurol, 1998, (3):Sl15-S120.
  • 7Faucheux BA, Bonnet AM, Agid Y, et al. Blood vessels change in the mesencephalon of patients with Parkinson's disease. Lancet, 1999, 353(9157):981-982.
  • 8Tada Oikawa S, Hiraku Y, Kawanishi M, et al. Mechanism for gen- eration of hydrogen peroxide and change of mitochondrial membrane potential during rotenone-induced apoptosis. Life Sciences, 2003,73 (25):3277-3288.
  • 9Bashkatova V, Alam M, Vanin A, et al. Chronic administration of rotenone increases levels of nitric oxide and lipid peroxidation products in rat brain. Experimental Neurology, 2004, 186 (2): 235-241.
  • 10Dr. Reynold Spector. Myo-inositol transport through the blood-brain barrier[J] 1988,Neurochemical Research(8):785~787

引证文献3

二级引证文献16

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部